Evidence map›Paper›PMID 32765780›Full record

ArticleExperimental and therapeutic medicine2020

Effects of matrine on the proliferation and apoptosis of vincristine-resistant retinoblastoma cells.

Bowen Zhao, Bin Li, Qian Liu, Fei Gao, Zhibao Zhang, Haixia Bai, Yichen Wang

RetractedErratum issuedOpen access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Biological Activity of Naturally Derived Naphthyridines.Molecules (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Bowen ZhaoBeijing Tongren Hospital, Beijing 100005, P.R. China.
Bin LiBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing 100005, P.R. China.
Qian LiuBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing 100005, P.R. China.
Fei GaoBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing 100005, P.R. China.
Zhibao ZhangBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing 100005, P.R. China.
Haixia BaiBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing 100005, P.R. China.
Yichen WangBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing 100005, P.R. China.
Capital Medical University · CNBeijing Tongren Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Matrine is an active component of

Indexed as

drug resistancematrineSO-Rb50vincristine-resistant retinoblastoma

Identifiers

PMID32765780
PMCPMC7401942
OpenAlexW3041260416

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.